The global Pen Needles Market is gaining momentum as the prevalence of diabetes increases and more patients rely on convenient, self-administered injection devices. Pen needles are small, sterile needles designed to attach to insulin pens and other medication delivery pens, enabling patients to administer prescribed medicines with greater convenience and precision. Their role in supporting routine diabetes management has made them an important component of the broader drug delivery and medical device industries.

Growing awareness of diabetes care, improvements in needle design, and rising demand for patient-friendly injection technologies are influencing the development of the market. Manufacturers are focusing on thinner needles, improved injection comfort, and safety features that help reduce accidental needlestick injuries. At the same time, the expanding use of injectable therapies is creating additional opportunities for pen needle manufacturers across developed and emerging healthcare markets.

Key market figures:

• Market size in 2025: USD 4.8 billion

• Estimated market size in 2026: USD 5.3 billion

• Projected market size by 2033: USD 9.9 billion

• CAGR: 9.4% from 2026 to 2033

• Largest regional market: Europe, with a 36.4% revenue share in 2025

Download a free sample copy of the Pen Needles Market report to understand detailed coverage and inclusions in the final report

Key Factors Driving the Pen Needles Market

1. Rising Prevalence of Diabetes

The increasing number of people living with diabetes is a primary driver of the pen needles market. Many patients with diabetes require regular insulin administration to manage blood glucose levels effectively. Insulin pens offer a practical alternative to conventional vial-and-syringe systems because they are portable, convenient, and designed to simplify dosing.

Pen needles are essential components of these devices and must generally be replaced after each injection. This creates recurring demand among patients who depend on insulin therapy over extended periods. The growing focus on early diagnosis, disease management, and patient education is also encouraging the use of suitable injection products.

2. Growing Preference for Home-Based Treatment

Home healthcare is becoming increasingly important as patients seek convenient ways to manage chronic conditions. Insulin pens and compatible pen needles allow many individuals to administer medication independently after receiving appropriate training from healthcare professionals.

This trend is creating opportunities for manufacturers to develop products that are easier to handle, comfortable to use, and suitable for different patient needs. Retail pharmacies, online distribution channels, and medical supply providers also help improve product accessibility.

3. Technological Advancements in Needle Design

Product innovation is another important growth factor. Manufacturers are developing thinner needles, shorter needle lengths, improved needle-tip geometries, and enhanced lubrication technologies to help improve injection comfort.

Safety pen needles are also gaining attention because protective mechanisms can help reduce accidental needlestick injuries. These products may be particularly relevant in healthcare settings where staff safety and proper sharps handling are essential.

Pen Needles Market Segmentation

Product Insights

The standard pen needles segment dominated the market with an 87.0% revenue share in 2025. Their broad use in routine insulin administration, availability across distribution channels, and compatibility with commonly used injection pens support demand.

Standard pen needles are widely used for long-term diabetes management, including treatment administered at home. Their established position and recurring replacement requirements make them a major source of market revenue.

Needle Length Insights

The 5mm needle-length segment accounted for 20.7% of market revenue in 2025, making it the leading segment by needle length. Shorter needle designs are of interest because they can help improve comfort and reduce the likelihood of injections reaching muscle tissue when used appropriately.

The 4mm segment is identified as the fastest-growing needle-length category in the report. Demand is supported by interest in shorter needles that can accommodate a range of patient needs. Healthcare professionals should guide patients on appropriate needle selection and injection technique rather than relying on needle length alone.

Therapy Insights

The insulin segment held the largest share of the pen needles market, accounting for 85.6% of revenue in 2025. This position reflects the essential role of insulin therapy in diabetes management and the recurring need for compatible injection accessories.

The market also includes pen needles used with glucagon-like peptide-1 (GLP-1) therapies and growth hormone treatments. Interest in injectable GLP-1 medicines for diabetes and weight management is creating additional opportunities for compatible pen needle products. Actual requirements depend on the prescribed medicine and delivery device.

Go Deeper! Ask Prism AI

about the Global Pen Needles Market. Get instant answers to

questions related to market sizing, growth drivers & their impact, and more.

Regional Analysis of the Pen Needles Market

Europe

Europe dominated the global pen needles market with a 36.4% revenue share in 2025. Its established healthcare infrastructure, access to diabetes treatment, and adoption of self-injection devices support regional demand. The region also benefits from established medical device distribution networks and attention to injection safety and product quality. 

North America

North America remains an important market for pen needles, supported by the substantial demand for diabetes care products and the adoption of convenient drug delivery devices. The United States is a major contributor to regional revenue.

Asia Pacific

Asia Pacific is expected to be the fastest-growing regional market over the 2026–2033 forecast period. Increasing demand for diabetes treatment, expanding healthcare infrastructure, and greater access to medical devices are contributing to the region's growth potential.

Latin America and the Middle East & Africa

Latin America and the Middle East & Africa offer further opportunities as diabetes awareness and access to healthcare services improve. Growth will depend on factors such as affordability, product availability, distribution infrastructure, and access to diagnosis and treatment. Manufacturers that establish reliable distribution partnerships and offer products suited to local healthcare needs may be better positioned to serve these markets.

Competitive Landscape and Industry Developments

The pen needles market features established medical device manufacturers and companies specializing in diabetes care. Competition is shaped by product quality, needle design, compatibility, manufacturing capacity, pricing, regulatory compliance, and distribution reach.

Key companies identified by Grand View Research include:

• Novo Nordisk A/S

• Becton, Dickinson and Company

• Terumo Corporation

• Owen Mumford Ltd.

• MTD Group

• B. Braun Melsungen AG

• HTL-STREFA

• UltiMed, Inc.

• Allison Medical, Inc.

• Artsana S.p.A. 

Companies are investing in product innovation and strategic expansion to strengthen their positions. Safety mechanisms, comfortable needle designs, and broader access to injection products are important areas of competition. At the same time, manufacturers must meet strict requirements concerning sterility, quality, labeling, and device compatibility.

Looking for more specific insights? Customize this report to suite your business needs